This deal will create a new company with an equity value of about C$4.8 billion ($3.8 billion), according to a statement and interviews with the Tilray and Aphria chief executive officers.
Hosted on MSN1mon
Tilray settles Aphria lawsuit for $21 millionAphria and the individual defendants have consistently ... This financial update is based on a press release statement from Tilray Brands, Inc. and the information contained in their recent ...
In other recent news, Tilray Brands, Inc. has reached a settlement agreement in a securities class action lawsuit involving its subsidiary, Aphria (NASDAQ:APHA), Inc. The settlement totals CAD $30 ...
Additionally, Tilray reached a settlement in a securities class action lawsuit against its subsidiary, Aphria, Inc., agreeing to an aggregate payment of approximately US $21 million. The ...
NEUMÜNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis ...
The next phase will see outdoor cultivation in Cayuga, Ontario this spring. Tilray’s key Canadian facilities, Aphria One and Aphria Diamond, are now fully operational and expected to ...
Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted and positioned to capture the growing demand from Canadian and International cannabis markets.
Tilray is well placed to profit from expanding global cannabis legalization. Investors must assess their risk tolerance due to Tilray's high stock volatility. Research Tilray's financial health ...
Javier Hasse This Week In Cannabis: DeSantis' Anti-Weed Push, NY's Drug Decriminalization, Aurora's Record Earnings, Tilray And More Global News Cannabis news: DeSantis fights Florida's 2026 ...
In other recent news, Tilray Brands, Inc. has reached a settlement agreement in a securities class action lawsuit involving its subsidiary, Aphria (NASDAQ:APHA), Inc. The settlement totals CAD $30 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results